Cancer medtech tops up Series B to $28 million
Sydney cancer medtech startup Lumonus, has added an additional $3 million to its Series B, four months on, to take ...
Sydney cancer medtech startup Lumonus, has added an additional $3 million to its Series B, four months on, to take ...
For medical device companies, choosing the right location for a manufacturing facility is one of the most significant ...
© 2024 Solega, LLC. All Rights Reserved | Solega.co
© 2024 Solega, LLC. All Rights Reserved | Solega.co